EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC 4.0

Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence

Arleen Aune, Annabel Ohldieck, Lene V Halvorsen, Karl Marius Brobak, Eirik Olsen, Stine Rognstad, Anne Cecilie K Larstorp, Camilla L Søraas, Anne B Rossebø, Assami Rösner, Marianne Aa Grytaas, Eva Gerdts

High Blood Pressure & Cardiovascular Prevention · 2024

DOI: 10.1007/s40292-024-00632-6 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift High Blood Pressure & Cardiovascular Prevention, 2024. Verfasst von Arleen Aune und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, University of Bergen, P.P. box 7804, 5020, Bergen, Norway. arleen.aune@uib.no. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Hypertrophy, Left Ventricular, Medication Adherence. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Norges Forskningsråd, Helse Vest Regionalt Helseføretak, Helse Sør-Øst RHF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Cardiac organ damage like left ventricular (LV) hypertrophy and left atrial (LA) enlargement is more prevalent in women than men with hypertension, but the mechanisms underlying this gender difference remain unclear. METHODS: We tested the association of drug nonadherence with the presence of LV hypertrophy and LA enlargement by echocardiography in 186 women and 337 men with uncontrolled hypertension defined as daytime systolic blood pressure (BP) ≥ 135mmHg despite the prescription of at least two antihypertensive drugs. Drug adherence was assessed by measurements of serum drug concentrations interpreted by an experienced pharmacologist. Aldosterone-renin-ratio (ARR) was measured on actual medication. RESULTS: Women had a higher prevalence of LV hypertrophy (46% vs. 33%) and LA enlargement (79% vs 65%, both p 0.514) did not differ. Women were older and had lower serum renin concentration and higher ARR than men, while 24-h systolic BP (141 ± 9 mmHg vs. 142 ± 9 mmHg), and the prevalences of obesity (43% vs. 50%) did not differ (all p > 0.10). In multivariable analyses, female gender was independently associated with a two-fold increased risk of LV hypertrophy (OR 2.01[95% CI 1.30-3.10], p = 0.002) and LA enlargement (OR 1.90 [95% CI 1.17-3.10], p = 0.010), while no association with drug nonadherence was found. Higher ARR was independently associated with LV hypertrophy in men only (OR 2.12 [95% CI 1.12-4.00] p = 0.02). CONCLUSIONS: Among patients with uncontrolled hypertension, the higher prevalence of LV hypertrophy and LA enlargement in women was not explained by differences in drug nonadherence. REGISTRATION: URL: https://www. CLINICALTRIALS: gov ; Unique identifier: NCT03209154.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsHypertensionHypertrophy, Left VentricularMedication AdherenceReninAgedFemaleHumansMaleMiddle AgedAldosteroneArterial PressureAtrial Function, LeftAtrial RemodelingBiomarkersCross-Sectional StudiesHealth Status DisparitiesPrevalenceRisk AssessmentRisk FactorsSex FactorsTreatment OutcomeVentricular Function, LeftVentricular Remodeling

Stichwörter der Autor:innen

Aldostero-Renin RatioCardiac organ damageDrug adherenceGenderLeft atrial enlargementLeft ventricular hypertrophyObesityPrimary aldosteronismSexUncontrolled hypertension

Substanzen

AldosteroneAntihypertensive AgentsBiomarkersRenin

Autor:innen und Institutionen

  • Department of Clinical Sciences, University of Bergen, P.P. box 7804, 5020, Bergen, Norway. arleen.aune@uib.no.
  • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway. arleen.aune@uib.no.
  • Department of Clinical Sciences, University of Bergen, P.P. box 7804, 5020, Bergen, Norway.
  • Department of Heart Disease, Haukeland University Hospital, Bergen, Norway.
  • Section for Cardiovascular and Renal Research, Oslo University Hospital Ullevål, Oslo, Norway.
  • Department of Nephrology, Oslo University Hospital Ullevål, Oslo, Norway.

Förderung

  • Norges Forskningsråd
  • Helse Vest Regionalt Helseføretak
  • Helse Sør-Øst RHF
  • University of Bergen

Zitieren

APA

Aune, A., Ohldieck, A., Halvorsen, L. V., Brobak, K. M., Olsen, E., Rognstad, S., Larstorp, A. C. K., Søraas, C. L., Rossebø, A. B., Rösner, A., Grytaas, M. A., & Gerdts, E. (2024). Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence. High Blood Pressure & Cardiovascular Prevention. https://doi.org/10.1007/s40292-024-00632-6

Vancouver

Aune A, Ohldieck A, Halvorsen LV, Brobak KM, Olsen E, Rognstad S, et al. Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence. High Blood Pressure & Cardiovascular Prevention. 2024. doi:10.1007/s40292-024-00632-6

BibTeX
@article{Aune2024,
  author = {Aune, Arleen and Ohldieck, Annabel and Halvorsen, Lene V and Brobak, Karl Marius and Olsen, Eirik and Rognstad, Stine and Larstorp, Anne Cecilie K and Søraas, Camilla L and Rossebø, Anne B and Rösner, Assami and Grytaas, Marianne Aa and Gerdts, Eva},
  title = {Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence},
  journal = {High Blood Pressure & Cardiovascular Prevention},
  year = {2024},
  doi = {10.1007/s40292-024-00632-6}
}
Kostenlos starten →